Authors
Latest:
An Overview of FDA Risk Evaluation & Mitigation StrategiesREMS are not intended to minimize all harmful effects of a drug, but instead focus on preventing, tracking, and handling a specific serious risk by informing, educating, and/or enforcing measures that reduce the frequency and/or intensity of the event.
Latest:
Insecticide Misuse With Cannabinoids and Its Resulting Complications: A Case ReportThe use of adulterated cannabinoids mixed with insecticides is becoming more common.
Latest:
Long-Acting HIV Regimen May Prove RevolutionaryFDA approval of 2-drug injectable Cabenuva is a game changer in maintaining viral suppression in patients.
Latest:
Revolutionizing Outpatient Oncology Care: The Seamless Integration of Artificial IntelligenceArtificial intelligence holds immense potential to address the rising demand for oncology services and improve patient outcomes by facilitating more effective, efficient, personalized cancer care.
Latest:
A 340B Compromise at Last? Draft Federal Legislation May Provide a Clear Path ForwardIn an ambitious effort to address the ongoing uncertainty within the 340B Program space, 6 senators released a draft discussion bill earlier this year titled the SUSTAIN Act.
Latest:
Shortages Persist in an Evolving ProfessionLow compensation, stressful environment spark technician exodus; replacing them has been difficult.
Latest:
Considerations for Environmentally Conscious Pharmacy StudentsEnvironmental conditions and air pollution affect health by causing injuries and fatalities, exacerbating respiratory and cardiovascular diseases, and spreading infectious diseases.
Latest:
The Financial, Clinical, and Human Role of Specialty Pharmacies in Ambulatory Infusion CentersAmbulatory infusion centers can help reduce the cost of care for payers and patients and allow pharmacists to contribute to a positive treatment experience.
Latest:
All Pharmacies Are Not the Same: Community Pharmacy QualityPatients and other stakeholders need to be able to compare pharmacies based on standardized, transparent metrics with a measurement system to make informed decisions.
Latest:
FDA Seeks to Regulate Laboratory-Developed TestsThe agency is looking to regulate them as medical devices.
Latest:
Computational Drug Repurposing Approaches Can Help Identify New Medications for Opioid Use DisorderFive medications (tramadol, olanzapine, mirtazapine, bupropion, and atomoxetine) were associated with significantly better OUD remission.
Latest:
Pharmacists Assist with Family Planning in Warfarin PatientsIn most patients who are pregnant or may become pregnant, warfarin is contraindicated due to increased risk of adverse fetal outcomes.
Latest:
The Pharmacist’s Role: Opioid-related Risks With a Psychiatric DrugPharmacists dispensing Lybalvi should understand that potentially life-threatening consequences can occur if opioids are taken concurrently.
Latest:
Investigative Report Leads to Changes in IllinoisChicago Tribune investigation on pharmacists’ time and workload sparks new regulations.
Latest:
Billing for Care Presents Challenges and OpportunitiesStrong support from pharmacy professionals and a shift in systems and workflows help pave the way for success.
Latest:
What’s Ahead in the Adalimumab Biosimilar Pipeline in DermatologyFDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.
Latest:
New Rules on Mandatory COVID-19 Vaccinations: Applicability to PharmaciesCMS Interim Final Rule on mandatory COVID-19 vaccinations for all facilities participating in Medicare and Medicaid potentially impacts pharmacies that provide services under a contract or arrangement with these facilities.
Latest:
The Impact of Community Pharmacists on Social Determinants of HealthHaving community pharmacists to influence outcomes associated with social determinants of health in the US population is vital to improving overall patient outcomes.
Latest:
Safe Medication Practices: Prevent Diversion During Drug DisposalBuilding a team to support best practices, medication safety, and staff education can reduce risks.
Latest:
Breaking Silos: How Health Systems and Manufacturers Can Drive Progress TogetherVanderbilt Specialty Pharmacy and Takeda Oncology are reaching across silos and entering an innovative partnership to improve patient care across the entire medication journey.
Latest:
Fourth-Year Pharmacy Students Help Patients and Practitioners in Transitional CareStudents are being exposed to new patient experiences through collaboration with practitioners.
Latest:
Osteoarthritis Management: Determine What Patients Know, Then Fill in GapsIn patients already using analgesics for pain control, pharmacists need to address medication adherence for improved osteoarthritis symptom control.
Latest:
Let’s Not Forget the Silent Killer: HypertensionThe prevalence of hypertension continues to increase amongst adults in the United States, leading to other cardiovascular conditions. Lifestyle changes and medication adherence are essential for appropriate hypertension management.
Latest:
Are OTC Proton Pump Inhibitors a Boon Or a Curse?The risk of therapy duplication with OTC and prescription PPIs can be lowered with an innovative, multi-faceted, and intentional approach by pharmacy teams and prescribers.
Latest:
Multisite Health-Systems Specialty Pharmacy Study Evaluates Adherence to Self-Administered Biologic Disease-Modifying Antirheumatic DrugsHigh adherence to treatment is a key first step toward better patient outcomes, including sustained disease control or remission.
Latest:
Three Strategies for Pharmacists to Maximize Their Potential as Caregivers Beyond the BenchIn recent years, pharmacist roles have evolved as critically important caregivers who increasingly provide essential health care services far beyond medication dispensing.
Latest:
Common Patient Questions About Insulin Biosimilars Pertain to ClassificationNuances can lead to frequent areas of confusion.
Latest:
Evaluation of a Chemotherapy Advanced Preparation Pilot Program to Improve Throughput in an Oncology Infusion ClinicPharmacy workflow changes in the preparation of chemotherapy products can reduce patient chair time.
